These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26772431)

  • 1. Challenges of clinical translation in nanomedicine: A qualitative study.
    Satalkar P; Elger BS; Hunziker P; Shaw D
    Nanomedicine; 2016 May; 12(4):893-900. PubMed ID: 26772431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
    Satalkar P; Elger BS; Shaw DM
    Sci Eng Ethics; 2016 Oct; 22(5):1255-1276. PubMed ID: 26373718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational nanomedicine: status assessment and opportunities.
    Murday JS; Siegel RW; Stein J; Wright JF
    Nanomedicine; 2009 Sep; 5(3):251-73. PubMed ID: 19540359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and nanomedicine for healthcare: challenges in translating innovations from bench to bedside.
    Bellare JR
    J Biomed Nanotechnol; 2011 Feb; 7(1):36-7. PubMed ID: 21485791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naming it 'nano': Expert views on 'nano' terminology in informed consent forms of first-in-human nanomedicine trials.
    Satalkar P; Elger BS; Shaw D
    Nanomedicine (Lond); 2016 Apr; 11(8):933-40. PubMed ID: 26979933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.
    Hartshorn CM; Russell LM; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine.
    Satalkar P; Elger BS; Shaw DM
    Curr Oncol; 2016 Dec; 23(6):e530-e537. PubMed ID: 28050141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
    Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
    Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering nanomedicines to patients: a practical guide.
    Eaton MA; Levy L; Fontaine OM
    Nanomedicine; 2015 May; 11(4):983-92. PubMed ID: 25724929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of nanobiology and nanomedicine].
    Xie SS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):469-71. PubMed ID: 16995294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues affecting nanomedicines on the way from the bench to the market.
    Longo JPF; Mussi S; Azevedo RB; Muehlmann LA
    J Mater Chem B; 2020 Dec; 8(47):10681-10685. PubMed ID: 33155000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerative nanotechnology in oral and maxillofacial surgery.
    Shakib K; Tan A; Soskic V; Seifalian AM
    Br J Oral Maxillofac Surg; 2014 Dec; 52(10):884-93. PubMed ID: 25218313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating nanomedicine and imaging.
    Pérez-Medina C; Hak S; Reiner T; Fayad ZA; Nahrendorf M; Mulder WJM
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of effective patents on future innovations in nanomedicine.
    Bosetti R; Vereeck L
    Pharm Pat Anal; 2012 Mar; 1(1):37-43. PubMed ID: 24236712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical nanotechnology: evolving appropriate risk tools.
    Moore R
    Med Device Technol; 2007 Sep; 18(5):36-7. PubMed ID: 17939370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery.
    Leary SP; Liu CY; Apuzzo ML
    Neurosurgery; 2006 Jun; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine.
    Bayda S; Adeel M; Tuccinardi T; Cordani M; Rizzolio F
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31892180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.